Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MEDP

Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector?

Charles River Laboratories has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Home Office will decide asylum claims of thousands stuck in Rwanda scheme limbo

Previous UK government had built up backlog of 90,000 people whose claims it deemed ‘inadmissible’

The Guardian - UK

3 Healthcare Stocks With High Profit Margins

With an aging population, increasing drug demand, and the development of advanced technologies, the healthcare industry is booming. Thus, it could be wise to invest in fundamentally sound healthcare stocks, Veeva Systems (VEEV), Align Technology (ALGN), and Medpace Holdings (MEDP), which have high-profit margins. Read on.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Uber Leads Five Stocks Near Buy Points

Uber, Axon and one more stock with the highest-possible rating from IBD lead this weekend's watch list.

Investors Business Daily

This Health Care Play Breaks Out After Doubling The Market's Gains

MEDP stock has broken out of a cup with handle and has climbed 29% this year. Medpace offers clinical trial and medical device support.

Investors Business Daily

Top-Notch Medpace Smashes Forecasts And Rockets 20% Toward A Record

Medpace Holdings easily beat third-quarter forecasts on Tuesday and netted a bullish number of new contracts. MEDP stock surged.

Investors Business Daily

Rwanda appeal decision ‘did not support or oppose any political view’ – judge

The Court of Appeal overturned the High Court’s finding that the east African nation could be considered a ‘safe third country’ for asylum seekers.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Boeing, CyberArk Lead 5 Stocks Near Buy Points

The market rally is going strong, but watch out for a potential pullback. Top stocks near buy points include Boeing and CyberArk.

Investors Business Daily

Medpace, A Top 1% Earnings Stock, Just Crushed Expectations — Here's A Key Measure To Watch

Medpace easily beat Wall Street's first-quarter projections late Monday and boosted its full-year outlook. In response, MEDP stock rocketed.

Investors Business Daily

Dow Jones Futures: Netflix Jumps On Subscribers, Google Slashing 12,000 Jobs After Market Rally Breaks Key Levels

The market rally suffered more damage as the S&P 500 fell below its 50-day line. Netflix subscriber growth easily beat. Google will cut 12,000 jobs.

Investors Business Daily

Dow Jones Futures Rise Ahead Of CPI Inflation Report; U.S.Airline Flights Grounded

Futures: The S&P 500 is back above its 50-day, but the CPI inflation report looms. An FAA glitch grounded U.S. domestic flights Wednesday morning.

Investors Business Daily

IBD Stock Of The Day Medpace Flashes Buy Signal — Why You Should Be Cautious

Medpace Holdings is Tuesday's IBD Stock Of The Day as MEDP stock bounces off its 50-day line amid bullish fourth-quarter expectations.

Investors Business Daily

Dow Jones Futures Rise To Start 2023; Tesla Falls On This Delivery Red Flag

Dow Jones futures kick off the 2023 stock market after a "stay away" year. Q4 Tesla deliveries hit a record, but missed lowered views again.

Investors Business Daily

Dow Jones Fall Heading Into Final Trading Day Of 2022; Tesla EV Credit Guidelines Add Confusion

Futures fell after a stock market rally attempt began Thursday. Tesla leapt amid new guidelines for EV credits that kick in Jan. 1.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures: S&P 500 Regains Key Level, But Stay Cautious; Tesla Doubles U.S. Discount To $7,500

The S&P 500 is above its 50-day, but the market rally is still shaky. Tesla doubled its year-end U.S. discount to $7,500.

Investors Business Daily

IBD Stock Of The Day Medpace Shocked Investors — Now It's Eyeing Multiple Entries

Medpace is the IBD Stock Of The Day. Months after a bullish 2023 call sent MEDP stock soaring, shares are eyeing a buy point.

Investors Business Daily

Dow Jones Futures Rise: 5 Stocks Near Buy Points In Market Rally; Tesla FSD Beta Expands Widely

The S&P 500 still faces its 200-day line with key economic data looming. Tesla FSD Beta gets a wide release after TSLA stock jumped from bear market lows.

Investors Business Daily

IBD 50 Stock Testing Buy Point After 38% One-Day Jump

After a huge gap-up on earnings last month, Medpace is researching a return to a prior buy point.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

IBD 50 Stocks To Buy And Watch: Medpace Breaks Out After 'Almost Unbelievable' Quarter

Medpace is one of the top stocks to buy and watch as it breaks out past its buy point after reporting "almost unbelievable" results.

Investors Business Daily

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

The Independent UK

Rwanda ‘not safe enough’ for asylum deal and Priti Patel must reconsider, parliamentary committee says

MPs and peers raise ‘fundamental concerns’ over compliance with international law

StockNews.com

Buy the Dip: 3 Oversold Healthcare Stocks

The healthcare industry has been in the limelight since the onset of the COVID-19 pandemic. The industry has seen a significant shift towards digital care, which could prove permanent and drive growth. Furthermore, with healthcare companies focusing on advanced technologies and innovations, the industry should keep thriving. So, we think…

Benzinga

Medpace Posts Better Than Expected Q1 Earnings, Lifts FYY22 Profit Outlook

Medpace Holdings Inc's (NASDAQ:MEDP) Q1 revenue increased 27.3% Y/Y to $330.9 million, beating the consensus of $327.09 million. On a constant currency organic basis, revenue increased 28.1%. As of March 31, 2022, the Backlog grew 28% to $2.1 billion. Net new business awards were $423 million, representing a net book-to-bill ratio of…

Benzinga

Earnings Preview: Medpace Hldgs

Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2022-04-25. Here's what investors need to know before the announcement. Analysts estimate that Medpace Hldgs will report an earnings per share (EPS) of $1.26.

Benzinga

Medpace Reports Mixed Q4 Earnings, Issues FY22 Guidance Ahead Of Estimates

Medpace Holdings Inc's (NASDAQ: MEDP)

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.